
0.8664 Delayed Data As of Feb 06 | ![]() Today’s Change | 0.59 Today|||52-Week Range 8.08 | -3.73% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Satsuma Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 17.00 and a low estimate of 1.00. The median estimate represents a +246.26% increase from the last price of 0.87.
The current consensus among 5 polled investment analysts is to Hold stock in Satsuma Pharmaceuticals Inc. This rating has held steady since December, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.